Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
25
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
NOTV
Inotiv
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Debt And Shifting Regulations Will Strain Performance But Prompt Recovery
Key Takeaways Shifting industry practices, high fixed costs, and integration risks threaten margin expansion and create uncertainty in revenue predictability and backlog conversion. Evolving alternatives to animal testing, rising debt costs, and client trends could undermine traditional revenue streams and weigh on future growth opportunities.
View narrative
US$2.50
FV
24.4% undervalued
intrinsic discount
4.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Skillz
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Delayed SEC Filings And NYSE Non-Compliance Will Constrain Expansion
Key Takeaways Persistent regulatory, legal, and compliance challenges are increasing operational costs and restricting market expansion, weighing on revenue growth and long-term margins. High user acquisition costs, reliance on third-party content, and shifting market trends threaten platform innovation, profitability, and sustained user growth.
View narrative
US$7.50
FV
14.4% overvalued
intrinsic discount
13.15%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
LiveOne
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Digital Rivals Will Restrict Deals While Future Potential Emerges
Key Takeaways Increasing competition, reliance on third-party deals, and shifting consumer habits may limit LiveOne's growth and challenge its long-term profitability. Operational improvements and balance sheet actions offer support, but persistent external risks threaten margin stability and recurring revenue sustainability.
View narrative
US$1.40
FV
57.1% undervalued
intrinsic discount
16.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Stem
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Policy Rollbacks And Supply Risks Will Threaten Energy Storage
Key Takeaways Exposure to policy, regulatory, and technology shifts in energy storage risks revenue and margin stability, especially with a narrow product focus and geographic concentration. Ongoing supply chain, debt, and market challenges threaten profitability and shareholder returns, even amid potential revenue growth.
View narrative
US$8.00
FV
109.3% overvalued
intrinsic discount
13.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Central Pacific Financial
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Experienced Leadership And Hawaii Market Focus Will Drive Future Success
Key Takeaways Experienced leadership appointments and focus on strategic growth are poised to enhance operational effectiveness and drive revenue growth for Central Pacific Financial. Strategic initiatives in market expansion, disciplined balance sheet management, and capital allocation are expected to boost profitability, earnings, and shareholder value.
View narrative
US$35.00
FV
12.1% undervalued
intrinsic discount
10.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
Vivos Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Acquisitions And Sleep Center Integrations Will Expand Future Markets
Key Takeaways Pivoting from dentist-led distribution to integrating with sleep medicine providers should boost margins, revenue growth, and capture more value from the sleep apnea market. Recent acquisitions and new business model aim for profitability, reduced cash burn, and capitalize on industry consolidation through a scalable expansion strategy.
View narrative
US$5.10
FV
17.6% undervalued
intrinsic discount
39.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
Vistra
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Increasing AI And Data Center Demand Will Energize Grid Flexibility
Key Takeaways Rising electricity demand, strategic contracts, and expanding into storage and renewables position Vistra for strong, diversified growth and improved profitability. Disciplined capital allocation and favorable market conditions enhance shareholder value, reduce risk, and support sustained earnings expansion.
View narrative
US$217.37
FV
12.4% undervalued
intrinsic discount
9.78%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
126
users have followed this narrative
3 days ago
author updated this narrative
Altamir
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
6X Leverage And Tech Exposure Will Depress Valuations
Key Takeaways Overreliance on tech sector growth and divestment-driven gains leaves earnings and portfolio value vulnerable to market shifts and normalization. Challenging exit environment, high leverage, and increased regulatory scrutiny threaten future private equity activity, margin expansion, and capital inflows.
View narrative
€28.50
FV
1.1% overvalued
intrinsic discount
-14.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
9 days ago
author updated this narrative
Galderma Group
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Global Aesthetics And Aging Trends Will Drive Expansion
Key Takeaways Accelerated growth and profitability are driven by innovative, premium products, digital engagement, and expanding presence in emerging markets. Strategic R&D investments and partnerships enhance Galderma's ability to capture rising demand for advanced dermatological and aesthetic solutions.
View narrative
CHF 136.99
FV
1.2% undervalued
intrinsic discount
14.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
8 days ago
author updated this narrative
Value any company in seconds
Popular companies